JP2003528814A5 - - Google Patents

Download PDF

Info

Publication number
JP2003528814A5
JP2003528814A5 JP2001528205A JP2001528205A JP2003528814A5 JP 2003528814 A5 JP2003528814 A5 JP 2003528814A5 JP 2001528205 A JP2001528205 A JP 2001528205A JP 2001528205 A JP2001528205 A JP 2001528205A JP 2003528814 A5 JP2003528814 A5 JP 2003528814A5
Authority
JP
Japan
Prior art keywords
xaa
alanine
peptide
hydroxymethylserine
valine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001528205A
Other languages
English (en)
Japanese (ja)
Other versions
JP5349722B2 (ja
JP2003528814A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/026952 external-priority patent/WO2001025265A1/en
Publication of JP2003528814A publication Critical patent/JP2003528814A/ja
Publication of JP2003528814A5 publication Critical patent/JP2003528814A5/ja
Application granted granted Critical
Publication of JP5349722B2 publication Critical patent/JP5349722B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001528205A 1999-10-01 2000-09-29 金属結合化合物およびその使用方法 Expired - Fee Related JP5349722B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15740499P 1999-10-01 1999-10-01
US60/157,404 1999-10-01
US21107800P 2000-06-13 2000-06-13
US60/211,078 2000-06-13
PCT/US2000/026952 WO2001025265A1 (en) 1999-10-01 2000-09-29 Metal-binding compounds and uses therefor

Publications (3)

Publication Number Publication Date
JP2003528814A JP2003528814A (ja) 2003-09-30
JP2003528814A5 true JP2003528814A5 (https=) 2007-11-15
JP5349722B2 JP5349722B2 (ja) 2013-11-20

Family

ID=26854102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001528205A Expired - Fee Related JP5349722B2 (ja) 1999-10-01 2000-09-29 金属結合化合物およびその使用方法

Country Status (11)

Country Link
EP (2) EP1220870B1 (https=)
JP (1) JP5349722B2 (https=)
KR (6) KR20020057966A (https=)
CN (2) CN102038932B (https=)
AT (1) ATE553116T1 (https=)
AU (1) AU770999C (https=)
BR (1) BR0014389A (https=)
CA (1) CA2385551A1 (https=)
IL (4) IL148797A0 (https=)
NZ (1) NZ518266A (https=)
WO (1) WO2001025265A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020160417A1 (en) * 2001-04-30 2002-10-31 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons
US20030040602A1 (en) * 2001-04-30 2003-02-27 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1406 daltons
WO2003043518A2 (en) * 2001-11-20 2003-05-30 Dmi Biosciences, Inc. Methods and products for oral care
JP5204947B2 (ja) 2002-11-27 2013-06-05 ディーエムアイ バイオサイエンシズ インコーポレイテッド リン酸受容体化合物の使用、ならびにリン酸受容体化合物を含んでいる、薬学的組成物、スキンケア用の組成物、およびキット
JP5265762B2 (ja) 2008-05-13 2013-08-14 ユニバーシティ・オブ・カンザス 金属抽出ペプチド（ｍａｐ）タグおよび関連する方法
WO2013181461A2 (en) 2012-06-01 2013-12-05 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
CN112094316B (zh) * 2017-06-29 2022-04-08 安徽省农业科学院农产品加工研究所 一种Ser和Cys分列在两端的高锌螯合活性锌鳌合肽及其应用
AU2021400952A1 (en) * 2020-12-15 2023-06-29 Life Technologies Corporation Chemically defined serum albumin substitutes
CN113563418B (zh) * 2021-06-22 2023-03-03 中国科学院化学研究所 一种原位响应ros的人工酶及其制备方法与应用
CN114437175B (zh) * 2022-01-29 2023-09-29 山东第一医科大学第三附属医院(山东省医学科学院附属医院) 一种肽探针及其应用和包含该肽探针的试剂盒

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941763A (en) 1975-03-28 1976-03-02 American Home Products Corporation PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
US4022888A (en) 1975-09-09 1977-05-10 Diagnostic Data, Inc. Esterified orgotein
US4461724A (en) 1981-10-28 1984-07-24 Nippon Zoki Pharmaceutical Co., Ltd. Peptide compounds, a process for manufacturing them, pharmaceutical compositions containing them, and methods for treating ulcer and thrombus with them
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
US4760051A (en) 1985-01-24 1988-07-26 Pickart Loren R Use of GHL-Cu as a wound-healing and anti-inflammatory agent
US5120831A (en) 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
US5214032A (en) 1985-02-08 1993-05-25 Procyte Corporation GHL-CU pharmaceutical compositions and compounds
US4877770A (en) 1985-02-08 1989-10-31 Procyte Corporation Chemical derivatives of GHL-Cu
US4767753A (en) 1985-02-08 1988-08-30 Procyte Corporation Methods and compositions for preventing ulcers
US4665054A (en) 1985-02-08 1987-05-12 Bioheal, Inc. Chemical derivatives of GHL-Cu
US5177061A (en) 1985-02-08 1993-01-05 Procyte Corporation Method for stimulating hair growth using GHL-Cu complexes
US5550183A (en) 1985-02-08 1996-08-27 Procyte Corporation Metal-peptide compositions and methods for stimulating hair growth
US4810693A (en) 1985-02-08 1989-03-07 Procyte Corporation Method for inducing biological coverings in wounds
US5348943A (en) 1985-02-08 1994-09-20 Procyte Corporation Cosmetic and skin treatment compositions
US5422096A (en) 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
JPS62116565A (ja) * 1985-11-15 1987-05-28 Fujisawa Pharmaceut Co Ltd 新規ペプチド
GB8603537D0 (en) 1986-02-13 1986-03-19 Parker D Conjugate compound
CA1323839C (en) 1987-05-11 1993-11-02 Loren Ralph Pickart Methods for stimulating hair growth
DE68917946T2 (de) 1988-01-29 1995-01-05 Peter H Proctor Haarwachstumanregung mit Nitroxyd und anderen Radikalen.
US5101041A (en) 1989-04-26 1992-03-31 The Curators Of The University Of Missouri Triamines and their derivatives as bifunctional chelating agents
US5443816A (en) 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
CA2065299C (en) 1989-08-09 2001-07-24 Buck A. Rhodes Direct radiolabeling of antibodies and other proteins with technetium or rhenium
US5759515A (en) 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications
US5460785A (en) 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
US5023237A (en) 1989-08-30 1991-06-11 Procyte Corporation Methods and compositions for healing ulcers
US5145838A (en) 1989-08-30 1992-09-08 Procyte Corporation Methods and compositions for healing ulcers
US5059588A (en) 1989-10-13 1991-10-22 Procyte Corporation, Incorporated Methods and compositions for healing bone using gly his lys: copper
US5118665A (en) 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
US5252559A (en) 1991-08-20 1993-10-12 The Procter & Gamble Company His-Gly-Gly peptide and derivatives thereof for hair growth
US5280038A (en) 1992-03-13 1994-01-18 Virginia Commonwealth University Histidine as a protective agent in cardiac surgery and myocardial ischemic syndrome
CA2094785A1 (en) 1992-05-08 1993-11-09 Jean Gariepy Metal chelating peptide
US5807535A (en) 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US5380747A (en) 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5650134A (en) 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
US5464934A (en) 1993-05-14 1995-11-07 Mallinckrodt Medical, Inc. Metal chelates as spacer compounds in biologically active peptides
US5994339A (en) 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
US5476939A (en) 1993-12-30 1995-12-19 Abbott Laboratories Certain pyridyl and isoquinolyl carbinolamine derivatives
JPH07316192A (ja) 1994-05-27 1995-12-05 Hoechst Japan Ltd Ｌ−リシル−グリシル−ｌ−ヒスチジンおよびこれを含有する創傷治療剤
US5538945A (en) 1994-06-17 1996-07-23 Procyte Corporation Stimulation of hair growth by peptide copper complexes
US5891418A (en) 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
EP0955044B1 (en) 1995-06-26 2005-11-16 Chelator LLC Method of inhibiting bacterial or fungal growth using a complexing agent
US5637311A (en) 1995-06-29 1997-06-10 Procyte Corporation Zinc(II) complexes and methods related thereto
RU2106146C1 (ru) 1995-07-17 1998-03-10 Институт элементоорганических соединений РАН Средство для подавления опухолевого роста
US5786335A (en) 1995-11-06 1998-07-28 Warner-Lambert Company Sulfhydryl containing peptides for treating vascular disease
US5928955A (en) 1996-03-22 1999-07-27 California Institute Of Technology Peptidyl fluorescent chemosensor for divalent zinc
WO1997044313A1 (en) 1996-05-21 1997-11-27 Novartis Ag N,N'-Di(2-HYDROXYBENZYL)ETHYLENEDIAMINE-N,N'-DIACETIC ACID DERIVATIVES
GB9613182D0 (en) 1996-06-24 1996-08-28 Nycomed Imaging As Method
PL184070B1 (pl) 1996-07-30 2002-08-30 Politechnika Lodzka Sposób wytwarzania peptydów zawierających a-hydroksymetyloserynę
US5906996A (en) 1996-08-21 1999-05-25 Murphy; Michael A. Tetramine treatment of neurological disorders
US5922761A (en) 1996-09-06 1999-07-13 Medinox, Inc. Methods for in vivo reduction of iron levels and compositions useful therefor
US5739395A (en) 1997-01-10 1998-04-14 University Of Florida Research Foundation, Inc. Method for synthesis of rhizoferrin
GB9711093D0 (en) 1997-05-29 1997-07-23 British Tech Group Novel orally active iron (III) chelators
DE69922787T2 (de) 1998-02-04 2005-12-15 University of Florida Research Foundation, Inc., Gainesville N,n'-bis(2-hydroxybenzyl)ethylendiamin-n,n'-diessigsäure und natriumsalze davon zur eisenchelatierungstherapie
DE19819843A1 (de) 1998-05-05 1999-11-11 Biotechnolog Forschung Gmbh Metallchelat bindende Peptide
CA2328457A1 (en) 1998-06-20 1999-12-29 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy

Similar Documents

Publication Publication Date Title
CA2078347C (en) Use of copper(ii) containing compounds to accelerate wound healing
WO2005028516A3 (en) Albumin-binding derivatives of therapeutic peptides
US20020123468A1 (en) Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease
US20240293511A1 (en) Hepcidin mimetics for treatment of hereditary hemochromatosis
RU2280039C2 (ru) Кахалалидные соединения
AU2009312235B2 (en) Aqueous composition containing follicle-stimulating hormone
JP2002530430A (ja) Ｃ型肝炎ウイルスｎｓ３プロテアーゼ阻害用の医薬組成物
CA2332817A1 (en) Il-6 antagonist peptides
JP6633523B2 (ja) Ｐｓｄ−９５の二量体阻害剤脂肪酸誘導体
JP2003528814A5 (https=)
EP0358234A2 (en) Intranasal calcitonin formulations
US9556229B2 (en) Modification of peptides using a bis(thioether)arylbridge approach
JP2004535461A5 (https=)
US5217956A (en) Composition and treatment with biologically active peptides and certain anions
JPS61143399A (ja) 塩基性ｖ↓１‐バソプレシン拮抗剤
JPH07316192A (ja) Ｌ−リシル−グリシル−ｌ−ヒスチジンおよびこれを含有する創傷治療剤
AU641129B2 (en) Composition and treatment with biologically active peptides and certain anions
JP3455542B2 (ja) オーレオバシジン類
JP2003510257A5 (https=)
JP2005517636A5 (https=)
CN102596894B (zh) 2-氨基-3-甲基-己-5-烯酸及其在制备肽如杆菌肽中的应用
WO2006101909A2 (en) Combination therapy for treating or preventing diseases
US20060275213A1 (en) Tumor targeting agents and uses thereof
DE10239832A1 (de) Sarcolysyl-Derivate und Verfahren zu deren Herstellung
US11667674B2 (en) Antibacterial cyclic lipopeptides